Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Impact of IL-6R Blockade for Cytokine Release Syndrome in Haploidentical Donor Stem Cell Transplant Patients on Infections, Clinical Outcomes and Immune Reconstitution

Katherine P Baker, MD, Roman M Shapiro, MD, Carol Reynolds, PhD, Benedetta Rambaldi, MD, Augustine Weber, Matilde Dal Boni, John Koreth, MBBS, DPhil, Corey Cutler, MD MPH, FRCPC, Joseph H. Antin, MD, Vincent T. Ho, MD, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, Catherine J. Wu, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Rizwan Romee, MD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-136390

Published: 2020

Journal Articles

Defibrotide: Real World Experience for Management of Veno-Occlusive Disease/ Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplantation

Mary Nauffal, MS,PharmD, Haesook T. Kim, PhD, Paul G. Richardson, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Corey Cutler, MD MPH, FRCPC, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, John Koreth, MBBS, DPhil, Roman M Shapiro, MD, Rizwan Romee, MD, Vincent T. Ho, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-135895

Published: 2020

Journal Articles

Cytokine-Induced Memory-like NK Cells Exhibit Massive Expansion and Long-Term Persistence after Infusion Post-Haploidentical Stem Cell Transplantation: A Report of the First Three Cases in a Phase I Trial

Roman M Shapiro, MD, Sarah Nikiforow, MD PhD, Benedetta Rambaldi, MD, Juliana Vergara, Heather Daley, Haesook T. Kim, PhD, Corey Cutler, MD MPH, FRCPC, Vincent T. Ho, MD, John Koreth, MBBS, DPhil, Mahasweta Gooptu, MD, Joseph H. Antin, MD, Jennifer Brock, Catherine J. Wu, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Rizwan Romee, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-133933

Published: 2020

Journal Articles

Safety and Efficacy of Adding Venetoclax to Reduced Intensity Conditioning Chemotherapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with High Risk Myeloid Malignancies

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134947

Published: 2020

Journal Articles

Quantitative Modeling of Azacitidine Resistance in Patients with Myelodysplastic Syndrome Identifies Distinct Phenotypes of Disease Progression: Evidence for the Presence of a Disease Versus Native Clone Effect

Roman M Shapiro, MD, Adam R Stinchcombe, PhD

Blood (2019) 134 (Supplement_1): 1723.

https://doi.org/10.1182/blood-2019-130332

Published: 2019

Journal Articles

High Interpatient Variability in Molecular MRD Response to Consolidation Chemotherapy in Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 1424.

https://doi.org/10.1182/blood-2019-122890

Published: 2019

Journal Articles

Quantitative Modeling of Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients Yields Distinct Clinical Phenotypes and Can Identify a State of Disease Predictive of Loss of Response to Azacitidine

Roman M Shapiro, MD, Alejandro Lazo-Langner, MD MSc, Adam R Stinchcombe, PhD

Blood (2018) 132 (Supplement 1): 3104.

https://doi.org/10.1182/blood-2018-99-115611

Published: 2018

Journal Articles

A Simple Tool for the Prediction of Azacytidine Treatment Failure in Patients with Myelodysplastic Syndrome

Roman M Shapiro, MD, Alejandro Lazo-Langner, MD MSc

Blood (2017) 130 (Supplement 1): 1706.

https://doi.org/10.1182/blood.V130.Suppl_1.1706.1706

Published: 2017

Journal Articles

Comparison of the IPSS and IPSS-R in Predicting Survival and Response of Myelodysplastic Syndrome Patients to 5-Azacitidine

Roman M Shapiro, MD, Alejandro Lazo-Langner, MD MSc, FRCPC

Blood (2016) 128 (22): 5550.

https://doi.org/10.1182/blood.V128.22.5550.5550

Published: 2016

NARROW

Impact of IL-6R Blockade for Cytokine Release Syndrome in Haploidentical Donor Stem Cell Transplant Patients on Infections, Clinical Outcomes and Immune Reconstitution

Defibrotide: Real World Experience for Management of Veno-Occlusive Disease/ Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplantation

Cytokine-Induced Memory-like NK Cells Exhibit Massive Expansion and Long-Term Persistence after Infusion Post-Haploidentical Stem Cell Transplantation: A Report of the First Three Cases in a Phase I Trial

Safety and Efficacy of Adding Venetoclax to Reduced Intensity Conditioning Chemotherapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with High Risk Myeloid Malignancies

Quantitative Modeling of Azacitidine Resistance in Patients with Myelodysplastic Syndrome Identifies Distinct Phenotypes of Disease Progression: Evidence for the Presence of a Disease Versus Native Clone Effect

High Interpatient Variability in Molecular MRD Response to Consolidation Chemotherapy in Acute Myeloid Leukemia

Quantitative Modeling of Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients Yields Distinct Clinical Phenotypes and Can Identify a State of Disease Predictive of Loss of Response to Azacitidine

A Simple Tool for the Prediction of Azacytidine Treatment Failure in Patients with Myelodysplastic Syndrome

Comparison of the IPSS and IPSS-R in Predicting Survival and Response of Myelodysplastic Syndrome Patients to 5-Azacitidine

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only